Keyphrases
Cardiovascular Disease
100%
Autoimmune Rheumatic Diseases
100%
Inflammation
66%
Premature Atherosclerosis
33%
Subclinical Cardiovascular Disease
33%
Vascular Inflammation
22%
APA®
22%
Subintimal
22%
Cardiovascular Prevention
11%
Rheumatoid Arthritis
11%
Heart Failure
11%
Hypertension
11%
Obesity
11%
Cardiovascular Risk
11%
Adipose Tissue
11%
Platelets
11%
Renal Disease
11%
Protective Effect
11%
Insulin Resistance
11%
Systemic Inflammation
11%
Hyperglycemia
11%
T Cells
11%
Epigenetic Mechanisms
11%
Atherosclerotic Lesions
11%
Vitamin D Deficiency
11%
Endothelial Cells
11%
Myocardium
11%
Vessel Wall
11%
Non-modifiable Risk Factors
11%
Atherogenesis
11%
Endothelial Progenitor Cells
11%
Cardiac Ischemia
11%
B Cells
11%
Cell Apoptosis
11%
Antiphospholipid Antibodies
11%
Antiphospholipid Syndrome
11%
Drug Target
11%
Autoimmunity
11%
Lipoproteins
11%
Vasculitis
11%
Hypothyroidism
11%
Disease-modifying Antirheumatic Drugs (DMARDs)
11%
Spondyloarthritis
11%
Periodontal Disease
11%
Prothrombotic State
11%
Small Vessels
11%
Vasa Vasorum
11%
Systemic Lupus Erythematosus
11%
Vascular Stiffness
11%
Inflammation Risk
11%
Immunologic Factors
11%
Aortic Aneurysm
11%
Systemic Sclerosis
11%
Immunological Abnormalities
11%
Complement Proteins
11%
Hyperuricemia
11%
Complement Deposition
11%
Sleep Apnea
11%
Ischemic Events
11%
Nonautoimmune
11%
INIS
cardiovascular diseases
100%
inflammation
100%
rheumatic diseases
100%
atherosclerosis
66%
diseases
22%
risks
22%
vessels
22%
complement
22%
ischemia
22%
apa
22%
antibodies
11%
patients
11%
biopsy
11%
walls
11%
hypertension
11%
drugs
11%
stiffness
11%
apoptosis
11%
arthritis
11%
kidneys
11%
proteins
11%
layers
11%
heart failure
11%
obesity
11%
adipose tissue
11%
sleep
11%
insulin
11%
lipoproteins
11%
hyperglycemia
11%
deposition
11%
vitamin d
11%
myocardium
11%
hypothyroidism
11%
lupus
11%
Immunology and Microbiology
Autoimmune Rheumatic Disease
100%
Atherosclerosis
66%
Vasculitis
33%
Insulin Resistance
11%
Systemic Inflammation
11%
Adipose Tissue
11%
Platelet
11%
Experimental Model
11%
T Cell
11%
Antiphospholipid Syndrome
11%
Autoimmunity
11%
Complement Component C4d
11%
Biological Product
11%
Endothelial Progenitor Cell
11%
B Cell
11%
Arterial Stiffness
11%
Systemic Scleroderma
11%
Systemic Lupus Erythematosus
11%
Inflammatory Arthritis
11%
Epigenetic Mechanism
11%
Complement Deposition
11%
Vasa Vasorum
11%
Immunologic Factor
11%
Drug Targeting
11%
Programmed Cell Death
11%
Lipoprotein
11%
Antiphospholipid Antibody
11%